Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy

Annals of Neurology

Volumn 44, Issue 3, 1998, Pages 341-349

  Berger, Joseph R ^a,c   Levy, Robert M ^b   Flomenhoft, Deborah ^a   Dobbs, Michael ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; BRAIN BIOPSY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK FACTOR; SURVIVAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AIDS-ASSOCIATED NEPHROPATHY; CD4 LYMPHOCYTE COUNT; CHILD; COHORT STUDIES; FEMALE; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; SURVIVORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031660161     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440309     Document Type: Article

References (55)

1. Major EO, Amemiya EE, Tornatore CS, et al. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JV virus-induced demyelinating disease of the human brain. Clin Microbiol 1992;5:49-73
2. Gillespie SM, Chang Y, Lemp G, et al. Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989. Ann Neurol 1991;30:597-604
3. Holman RC, Janssen RS, Buehler JW, et al. Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology 1991;41:1733-1736
4. Krupp LB, Lipton RB, Swerdlow ML, et al. Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 1985;17:344-349
5. Berger JR, Kaszovitz B, Post JD, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature and report of 16 cases. Ann Intern Med 1987;107:78-87
6. Stoner GL, Ryschkewitsch CF, Walker DL, Webster HD. JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 1986;23:2271-2275
7. Lang W, Miklossy J, Deruaz JP, et al. Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (Berl) 1989;77:379-390
8. Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric and fetal brains. Hum Pathol 1991;22:700-710
9. Kuchelmeister K, Gullotta F, Bergmann M, et al. Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Pathol Res Pract 1993;189:163-173
10. Whiteman M, Post MJD, Berger JR, et al. PML in 47 HIV+ patients. Radiology 1993;187:233-240
11. Hedley-Whyte ET, Smith BP, Tyler HR, Peterson WP. Multifocal leukoencephalopathy wich remission and five-year survival. J Neuropathol Exp Neurol 1966;25:107-116
12. Stam FC. Multifocal leuko-encephalopathy with slow progression and very long survival. Psychiatr Neurol Neurochir 1966;69:453-459
13. Bolton CF, Rozdilsky B. Primary progressive multifocal leukoencephalopathy. A case report. Neurology 1971;21:72-77
14. Kepes JJ, Chou SM, Price LW. Progressive multifocal leukoencephalopathy with 10 year survival in a patient with nontropical sprue. Neurology 1975;25:1006-1012
15. Selhorst JB, Ducy KF, Thomas JM, et al. PML: remission and immunologic reversals. Neurology 1978;28:337 (Abstract)
16. Price RW, Nielsen S, Horten B, et al. Progressive multifocal leukoencephalopathy: a burnt-out case. Ann Neurol 1983;13:485-490
17. Schlitt M, Morawetz RB, Bonnin J, et al. Progressive multifocal leukoencephalopathy: three patients diagnosed by brain biopsy, with prolonged survival in two. Neurosurgery 1986;18:407-414
18. Embrey JR, Silva FG, Helderman JH, et al. Long-term survival and late development of bladder cancer in renal transplant patient with progressive multifocal leukoencephalopathy. J Urol 1988;139:580-581
19. Berger JR, Mucke L. Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 1988;38:1060-1064
20. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance of definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-4
21. Berger JR, Scott G, Albrecht J, et al. Progressive multifocal leukoencephalopathy in HIV-1-infected children. AIDS 1992;6:837-841
22. Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984;2:299-313
23. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998;4:59-68
24. Fong IW, Toma E. The natural history of progressive multifocal leukoencephalopathy in patients with AIDS Canadian PML study group. Clin Infect Dis 1995;20:1305-1310
25. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996;124:633-642
26. Padgett BL, Walker DL. Virologic and serologic studies of progressive multifocal leukoencephalopathy. In: Sever JL, Madden DL, eds. Polyoma viruses and human neurological disease. New York: Alan R. Liss, 1983:107-117
27. Portegies P, Algra PR, Hollar CEM, et al. Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991;337:680-681
28. Lortholary O, Pialoux G, Dupont B, et al. Prolonged survival of a patient with AIDS and progressive multifocal leukoencephalopathy. Clin Infect Dis 1994;18:826-827
29. Nicoli F, Chave B, Peragut JC, Gastaut JL. Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1992;339:306 (Letter)
30. Lindman C, Lindqvist L, Mathiesen T, Grane P. Progressive multifocal leukoencephalopathy in AIDS. AIDS 1991;5:1039-1041
31. Bauer WR, Turel AP Jr, Johnson KP. Progressive multifocal leukoencephalopathy and cytarabine: remission with treatment. JAMA 1973;226:174-176
32. Marriott PJ, O'Brien MD, MacKenzie CCK, Janota I. Progressive multifocal leucoencephalopathy: remission with cytarabine. J Neurol Neurosurg Psychiatry 1975;38:205-209
33. Peters ACB, Versteg J, Bots GTAM, et al. Progressive multifocal leukoencephalopathy: immunofluorescent demonstration of simian virus 40 antigen in CSF cells and response to cytarabine therapy. Arch Neurol 1980;37:497-501
34. Conomy JP, Beard NS, Matsumoto H, Roessmann U. Cytarabine treatment of progressive multifocal leukoencephalopathy. JAMA 1974;229:1313-1316
35. Buckman R, Wiltshaw E. Progressive multifocal leukoencephalopathy successfully treated with cytosine arabinoside. Br J Haematol 1976;34:153-154 (Letter)
36. O'Riordan T, Daly PA, Hutchinson M, et al. Progressive multifocal leukoencephalopathy - remission with cytarabine. J Infect Dis 1990;20:51-54
37. de Truchis P, Flament-Saillour M, Urtizberea J-A, et al. Inefficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1993;342:622-623 (Letter)
38. Hall CD, Dafni U, Simpson D, et al. Failure of cytosine arabinoside therapy of human immunodeficiency virus-1 associated progressive multifocal leukoencephalopathy. N Engl J Med (In press)
39. Singer EJ, Stoner GL, Singer P, et al. AIDS presenting as progressive multifocal leukoencephalopathy with clinical response to zidovudine. Acta Neurol Scand 1994;90:443-447
40. Conway B, Halliday WC, Brunham RE. Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: apparent response to 3′-azido-3′-deoxythymidine. Rev Infect Dis 1990;12:479-482
41. Martin-Suarez I, Aguayo Canela M, Merino Munoz D, Pujol de la Llave E. Prolonged survival in patients with progressive multifocal leukoencephalopathy associated with AIDS treated with high doses of zidovudine. Rev Clin Esp 1994;194:136-138 (Letter)
42. Fiala M, Cone LA, Cohen N, et al. Responses of neurologic complications of AIDS to 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl) guanine. I. Clinical features. Rev Infect Dis 1988;10:250-256
43. Huang SS, Skolasky RL, Dal Pan GJ, et al. Survival prolongation and symptom palliation in HIV-seropositive patients with progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol 1998;4:324-332
44. Aksamit AJ, Gendelman HE, Orenstein JM, Pezeshkpour GH. AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohistochemistry. Neurology 1990;40:1073-1078
45. Hair LS, Nuovo G, Sisti M, et al. Progressive multifocal leukoencephalitis in HIV. Int Cong Neuropathol 1990;11:116 (Abstract)
46. Richardson EP Jr, Johnson PC. Atypical progressive multifocal leukoencephalopathy with plasma cell infiltrates. Symposium on malignant lymphomas of the nervous system, Vienna, 1974. Acta Neuropathol 1975;(Suppl 6):247-250
47. Richardson EP Jr. Progressive multifocal leukoencephalopathy. N Engl J Med 1961;265:815-823
48. Walker DL. Progressive multifocal leukoencephalopathy: an opportunistic viral infection of the central nervous system. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 34: infections of the nervous system, part II. Amsterdam: Elsevier North-Holland Biomedical, 1985:307-329
49. Mancall EL. Progressive multifocal leukoencephalopathy. Neurology 1965;15:693-699
50. Krempien B, Kolkmann F-W, Schiemer HG, Mayer P. Über die progressive multifoccale Leukeoencephalopathie. Virchows Arch [A] 1972;355:158-178
51. Willoughby E, Price RW, Padgett BL, et al. Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus. Neurology 1980;30:256-262
52. Houff SA. Neuroimmunology of human immunodeficiency virus infection. In: Berger JR, Levy RM, eds. AIDS and the nervous system. 2nd ed. Philadelphia: Lippincott-Raven, 1997:77-122
53. Baqi M, Kucharczyk W, Walmsley SL. Regression of progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1997;11:1526-1527
54. Jones PD, Shelley L, Wakefield D. Tumor necrosis factor-alpha in advanced HIV infection in the absence of AIDS related secondary infections. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5:1266-1271
55. Fauci AS, Rosenberg ZF. Immunopathogenesis. In: Broder S, Merigan TC Jr, Bolognesi D, eds. Textbook of AIDS medicine. Baltimore: Williams and Wilkins, 1994:55-75